南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

3-羟基蒽林酸通过YY1-p53和YY1-DKK4信号通路抑制结肠直肠癌生长并增强5-氟尿嘧啶的敏感性

3-hydroxyanthranilic acid suppresses colorectal cancer growth and enhances 5-fluorouracil sensitivity via the YY1-p53 and YY1-DKK4 axes

Guifang Gan, Chengfang Shangguan, Yuan Yuan, Suoyu Xiang, Zhaopeng Shi

Journal:Frontiers in Pharmacology

IF:5.4

DOI:10.3389/fphar.2026.1928654

PMID:42835308

Published:2026-09-21

research field:肿瘤学分子生物学癌症研究细胞生物学生物化学

Abstract

Introduction The tryptophan metabolite 3-hydroxyanthranilic acid (3-HAA) has been reported to exert tumor-growth-inhibitory activity; however, its functional role and underlying mechanisms in colorectal cancer (CRC) remain largely unexplored. Methods We measured 3-HAA levels in CRC tissues and evaluated its effects on CRC cell proliferation through exogenous administration. Mechanistic investigations were performed to identify its direct protein targets and downstream signaling pathways. The therapeutic potential of 3-HAA, alone and in combination with 5-fluorouracil (5-FU), was assessed both in vitro and in vivo using cell line-derived xenograft mouse model and AOM/DSS-induced colorectal tumor mouse model. Results 3-HAA exhibited depleted levels in CRC tissues, and its exogenous administration effectively suppressed the proliferation of multiple CRC cell lines. Through its binding to the Yin Yang 1 (YY1) transcription factor, it disrupted the YY1-p53 interaction, preserved p53 stability, and induced cell cycle arrest. Notably, in vitro , 3-HAA reduced chemoresistance to the common CRC-chemotherapy drug 5-fluorouracil (5-FU) via the YY1-DKK4 axis. Consistently, in vivo , combined 3-HAA-5-FU treatment effectively inhibited CRC progression. Discussion Our findings demonstrate that 3-HAA functions as a tumor suppressor in CRC by targeting the YY1–p53 axis and enhancing chemosensitivity to 5-FU. These results highlight the potential of 3-HAA as a promising therapeutic agent for CRC treatment.

本文使用的Yeasen产品

产品应用
购物车
客服
转染试用